Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.

Saved in:
Bibliographic Details
Title: Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
Authors: Quiroz YT; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia. Electronic address: yquiroz@mgh.harvard.edu., Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden., Reiman EM; Banner Alzheimer's Institute, Phoenix, AZ, USA; University of Arizona College of Medicine, Phoenix AZ, USA; Arizona State University, Tempe, AZ, USA; Translational Genomics Research Institute, Phoenix, AZ, USA., Chen Y; Banner Alzheimer's Institute, Phoenix, AZ, USA., Su Y; Banner Alzheimer's Institute, Phoenix, AZ, USA., Fox-Fuller JT; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA., Garcia G; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia., Villegas A; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia., Sepulveda-Falla D; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Villada M; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia., Arboleda-Velasquez JF; Schepens Eye Research Institute of Mass, Eye and Ear, Harvard Medical School, Boston, MA., Guzmán-Vélez E; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Vila-Castelar C; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Gordon BA; Knight Alzheimer's Disease Research Center, Washington University in St Louis, St Louis, MO, USA., Schultz SA; Knight Alzheimer's Disease Research Center, Washington University in St Louis, St Louis, MO, USA., Protas HD; Banner Alzheimer's Institute, Phoenix, AZ, USA., Ghisays V; Banner Alzheimer's Institute, Phoenix, AZ, USA., Giraldo M; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia., Tirado V; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia., Baena A; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia., Munoz C; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia., Rios-Romenets S; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia., Tariot PN; Banner Alzheimer's Institute, Phoenix, AZ, USA; University of Arizona College of Medicine, Phoenix AZ, USA., Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden., Lopera F; Grupo de Neurociencias de Antioquia of Universidad de Antioquia, Medellín, Colombia.
Source: The Lancet. Neurology [Lancet Neurol] 2020 Jun; Vol. 19 (6), pp. 513-521. Date of Electronic Publication: 2020 May 26.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-4465
DOI:10.1016/S1474-4422(20)30137-X